Published in J S C Med Assoc on December 01, 2002
Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care (2002) 5.60
Depression and all-cause and coronary heart disease mortality among adults with and without diabetes. Diabetes Care (2005) 3.13
Research capacity. Enabling the genomic revolution in Africa. Science (2014) 3.05
Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes (2003) 2.79
The Green Prescription: a field of dreams? N Z Med J (2003) 2.67
The prevalence and pattern of complementary and alternative medicine use in individuals with diabetes. Diabetes Care (2002) 2.35
Racial/ethnic differences in influenza vaccination coverage in high-risk adults. Am J Public Health (2003) 2.29
Independent factors associated with major depressive disorder in a national sample of individuals with diabetes. Diabetes Care (2003) 2.15
Critical evaluation of adult treatment panel III criteria in identifying insulin resistance with dyslipidemia. Diabetes Care (2004) 2.11
Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial. Circulation (2005) 2.02
The metabolic syndrome and CVD outcomes for a central Australian cohort. Diabetes Res Clin Pract (2013) 1.97
Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort. Invest Ophthalmol Vis Sci (2004) 1.89
Community advisory boards in community-based participatory research: a synthesis of best processes. Prev Chronic Dis (2011) 1.72
Retinal vascular caliber and risk of retinopathy in young patients with type 1 diabetes. Ophthalmology (2006) 1.72
Randomized study comparing a Basal-bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial. Diabetes Care (2013) 1.57
REACH 2010: Charleston and Georgetown Diabetes Coalition approaches to reducing disparities for African Americans with diabetes. S C Nurse (2003) 1.56
Prediction of myocardial infarction by N-terminal-pro-B-type natriuretic peptide, C-reactive protein, and renin in subjects with cerebrovascular disease. Circulation (2005) 1.55
High concentrations of AGE-LDL and oxidized LDL in circulating immune complexes are associated with progression of retinopathy in type 1 diabetes. Diabetes Care (2012) 1.55
Renal kallikrein: a risk marker for nephropathy in children with sickle cell disease. J Pediatr Hematol Oncol (2006) 1.45
Quantitative assessment of early diabetic retinopathy using fractal analysis. Diabetes Care (2008) 1.41
Modifiable cardiovascular risk factors in adults with diabetes: prevalence and missed opportunities for physician counseling. Arch Intern Med (2002) 1.39
Reducing disparities for African Americans with diabetes: progress made by the REACH 2010 Charleston and Georgetown Diabetes Coalition. Public Health Rep (2004) 1.33
Racial/ethnic differences in adult vaccination among individuals with diabetes. Am J Public Health (2003) 1.30
Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy. Kidney Int (2003) 1.30
Systemic and vascular inflammation is elevated in early IgA and type 1 diabetic nephropathies and relates to vascular disease risk factors and renal function. Nephrol Dial Transplant (2005) 1.28
Risk factors related to inflammation and endothelial dysfunction in the DCCT/EDIC cohort and their relationship with nephropathy and macrovascular complications. Diabetes Care (2008) 1.27
Retinal arteriolar dilation predicts retinopathy in adolescents with type 1 diabetes. Diabetes Care (2008) 1.25
Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort: associations with gender and glycemia. Diabetes Care (2003) 1.22
Why should a doctor be interested in oral disease? Expert Rev Cardiovasc Ther (2010) 1.18
Immune complexes containing modified lipoproteins are related to the progression of internal carotid intima-media thickness in patients with type 1 diabetes. Atherosclerosis (2006) 1.15
Associations between liver histology and severity of the metabolic syndrome in subjects with nonalcoholic fatty liver disease. Diabetes Care (2005) 1.14
Fibrinogen is a marker for nephropathy and peripheral vascular disease in type 1 diabetes: studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort. Diabetes Care (2003) 1.12
Therapeutic effects of PPARα agonists on diabetic retinopathy in type 1 diabetes models. Diabetes (2012) 1.08
Benefits and safety of long-term fenofibrate therapy in people with type 2 diabetes and renal impairment: the FIELD Study. Diabetes Care (2011) 1.08
Comparison of arterial assessments in low and high vascular disease risk groups. Am J Hypertens (2004) 1.07
Associations of inflammatory and hemostatic variables with the risk of recurrent stroke. Stroke (2005) 1.07
Nonenzymatic glycation impairs the antiinflammatory properties of apolipoprotein A-I. Arterioscler Thromb Vasc Biol (2010) 1.06
Plasma prekallikrein: a risk marker for hypertension and nephropathy in type 1 diabetes. Diabetes (2003) 1.06
A community-based participatory health information needs assessment to help eliminate diabetes information disparities. Health Promot Pract (2006) 1.03
Improving diabetes management with mobile health technology. Am J Med Sci (2013) 1.02
Increased methionine sulfoxide content of apoA-I in type 1 diabetes. J Lipid Res (2008) 1.02
Inflammation and vascular endothelial activation in an Aboriginal population: relationships to coronary disease risk factors and nutritional markers. Med J Aust (2003) 1.01
Retinal vascular fractal dimension and risk of early diabetic retinopathy: A prospective study of children and adolescents with type 1 diabetes. Diabetes Care (2009) 1.00
Retinal arteriolar tortuosity is associated with retinopathy and early kidney dysfunction in type 1 diabetes. Am J Ophthalmol (2011) 0.96
Chemical modification of proteins during peroxidation of phospholipids. J Lipid Res (2005) 0.96
Differences in myocardial structure and coronary microvasculature between men and women with coronary artery disease. Hypertension (2010) 0.96
Serum carotenoids and fat-soluble vitamins in women with type 1 diabetes and preeclampsia: a longitudinal study. Diabetes Care (2011) 0.95
Retinal vascular geometry predicts incident retinopathy in young people with type 1 diabetes: a prospective cohort study from adolescence. Diabetes Care (2011) 0.94
Prediction of heart failure by amino terminal-pro-B-type natriuretic peptide and C-reactive protein in subjects with cerebrovascular disease. Hypertension (2004) 0.94
Impact of type 2 diabetes and the metabolic syndrome on myocardial structure and microvasculature of men with coronary artery disease. Cardiovasc Diabetol (2011) 0.93
Phenotyping Stroke in Sub-Saharan Africa: Stroke Investigative Research and Education Network (SIREN) Phenomics Protocol. Neuroepidemiology (2015) 0.93
Apolipoprotein C-III protein concentrations and gene polymorphisms in Type 1 diabetes: associations with microvascular disease complications in the DCCT/EDIC cohort. J Diabetes Complications (2005) 0.92
A review of systematic reviews evaluating diabetes interventions: focus on quality of life and disparities. Diabetes Educ (2008) 0.92
Position statement of the Australian Diabetes Society: individualisation of glycated haemoglobin targets for adults with diabetes mellitus. Med J Aust (2009) 0.91
Soluble vascular cell adhesion molecule 1 and N-terminal pro-B-type natriuretic peptide in predicting ischemic stroke in patients with cerebrovascular disease. Arch Neurol (2005) 0.91
Advanced glycation end products and diabetic complications. Expert Opin Investig Drugs (2002) 0.91
Association between PON 1 polymorphisms, PON activity and diabetes complications. J Diabetes Complications (2006) 0.91
An update on the molecular actions of fenofibrate and its clinical effects on diabetic retinopathy and other microvascular end points in patients with diabetes. Diabetes (2013) 0.90
Liberal Glycemic Control in Critically Ill Patients With Type 2 Diabetes: An Exploratory Study. Crit Care Med (2016) 0.89
NMR-determined lipoprotein subclass profile predicts type 2 diabetes. Diabetes Res Clin Pract (2008) 0.89
Cross-sectional associations of C-reactive protein with vascular risk factors and vascular complications in the DCCT/EDIC cohort. J Diabetes Complications (2008) 0.88
Are ankle and toe brachial indices (ABI-TBI) obtained by a pocket Doppler interchangeable with those obtained by standard laboratory equipment? J Wound Ostomy Continence Nurs (2007) 0.87
Diastolic dysfunction of aging is independent of myocardial structure but associated with plasma advanced glycation end-product levels. PLoS One (2012) 0.87
Long-term fenofibrate therapy increases fibroblast growth factor 21 and retinol-binding protein 4 in subjects with type 2 diabetes. J Clin Endocrinol Metab (2012) 0.85
Telehealth in Australia: an evolution in health care services. Med J Aust (2013) 0.85
A survey of oral health education provided by certified diabetes educators. Diabetes Res Clin Pract (2010) 0.83
C-reactive protein concentrations are very high and more stable over time than the traditional vascular risk factors total cholesterol and systolic blood pressure in an Australian aboriginal cohort. Clin Chem (2008) 0.83
The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study. Diabetologia (2014) 0.83
Retinal vascular geometry predicts incident renal dysfunction in young people with type 1 diabetes. Diabetes Care (2012) 0.83
A narrative review on haptic devices: relating the physiology and psychophysical properties of the hand to devices for rehabilitation in central nervous system disorders. Disabil Rehabil Assist Technol (2012) 0.82
Normalized NEFA dynamics during an OGTT after islet transplantation. Transplantation (2012) 0.82
Beyond the medical model: interdisciplinary programs of community-engaged health research. Clin Transl Sci (2011) 0.81
Oxidative stress and high-density lipoprotein function in Type I diabetes and end-stage renal disease. Clin Sci (Lond) (2005) 0.81
Glycation does not alter LDL-induced secretion of tissue plasminogen activator and plasminogen activator inhibitor-1 from human aortic endothelial cells. Ann N Y Acad Sci (2005) 0.81
Exercise frequency and arterial compliance in non-diabetic and type 1 diabetic individuals. Eur J Cardiovasc Prev Rehabil (2006) 0.81
People with diabetes: knowledge, perceptions, and applications of recommendations for diabetes management. Ethn Dis (2004) 0.81
Associations among smoking status, lifestyle and lipoprotein subclasses. J Clin Lipidol (2010) 0.80
High density lipoproteins bind Abeta and apolipoprotein C-II amyloid fibrils. J Lipid Res (2006) 0.80
Serum apolipoproteins are associated with systemic and retinal microvascular function in people with diabetes. Diabetes (2012) 0.80
Apolipoprotein C-III protein concentrations and gene polymorphisms in type 1 diabetes: associations with lipoprotein subclasses. Metabolism (2004) 0.80
Lipid-free apolipoprotein A-I and discoidal reconstituted high-density lipoproteins differentially inhibit glucose-induced oxidative stress in human macrophages. Arterioscler Thromb Vasc Biol (2011) 0.80
The vascular endothelium in diabetes: a practical target for drug treatment? Expert Opin Ther Targets (2005) 0.80
Increased coated-platelet levels in chronic haemodialysis patients. Nephrology (Carlton) (2009) 0.80
Reduced microvascular density in non-ischemic myocardium of patients with recent non-ST-segment-elevation myocardial infarction. Int J Cardiol (2012) 0.80
Association between p.Leu54Met polymorphism at the paraoxonase-1 gene and plantar fascia thickness in young subjects with type 1 diabetes. Diabetes Care (2008) 0.79
Low plasma concentrations of diet-derived antioxidants in association with microalbuminuria in Indigenous Australian populations. Clin Sci (Lond) (2003) 0.79
Lipid-derived modifications of plasma proteins in experimental and human diabetes. Ann N Y Acad Sci (2005) 0.79
Apolipoprotein A-I glycation by glucose and reactive aldehydes alters phospholipid affinity but not cholesterol export from lipid-laden macrophages. PLoS One (2013) 0.79
Plantar fascia thickness is longitudinally associated with retinopathy and renal dysfunction: a prospective study from adolescence to adulthood. J Diabetes Sci Technol (2012) 0.79
Plastic contaminant masquerades as DNA in mutation detection by denaturing HPLC. Biotechniques (2003) 0.78
Serum inflammatory markers and preeclampsia in type 1 diabetes: a prospective study. Diabetes Care (2013) 0.78
LDL-containing immune complexes in the DCCT/EDIC cohort: associations with lipoprotein subclasses. J Diabetes Complications (2010) 0.78
Cardiovascular risk factors in pre-pubertal Malays: effects of diabetic parentage. Diabetes Res Clin Pract (2006) 0.78
Plasma lipoproteins and preeclampsia in women with type 1 diabetes: a prospective study. J Clin Endocrinol Metab (2012) 0.78
Favourable effects of fenofibrate on lipids and cardiovascular disease in women with type 2 diabetes: results from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetologia (2014) 0.78